Skip to main content

Table 1 Baseline characteristics of participants in RAMP-DM group and usual care group

From: Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study

 

RAMP-DM (N = 1072)

Usual care (N = 1072)

 
 

Mean ± SD or n(%)

P-valuea

Demographic

Age (year)

64.3 ± 10.9

65.3 ± 11.7

0.056

Male

534 (49.8%)

534 (49.8%)

1.000

Smokers

106 (9.9%)

90 (8.4%)

0.231

Cluster information

  

0.767

HKEC

268 (25.0%)

278 (25.9%)

 

KCC

270 (25.2%)

274 (25.6%)

 

KWC

256 (23.9%)

262 (24.4%)

 

NTEC

278 (25.9%)

258 (24.1%)

 

Clinical

T2DM

1064 (99.5%)

1006 (93.8%)

<0.001

Duration of DM (year)

7.9 ± 6.2

7.9 ± 6.6

0.759

HbA1c (%)

7.26 ± 1.17

7.13 ± 1.17

0.033

TC(mmol/L)

5.05 ± 0.96

4.87 ± 0.94

<0.001

HDL-C (mmol/L)

1.23 ± 0.34

1.23 ± 0.33

0.830

LDL-C (mmol/L)

3.10 ± 0.80

2.89 ± 0.79

<0.001

Triglycerides (mmol/L)

1.63 ± 1.08

1.56 ± 1.00

0.2495

SBP ≤ 140 mmHg

615 (58.7%)

634 (69.3%)

<0.001

DBP ≤ 80 mmHg

700 (66.8%)

687 (75.1%)

<0.001

SBP/DBP ≤ 140/80 mmHg

538 (58.8%)

491 (46.9%)

<0.001

No(%) reaching treatment target

HbA1c < 7%

467 (50.54%)

384 (54.9%)

0.079

SBP < 130 mmHg

365 (34.8%)

412 (45.0%)

<0.001

DBP < 80 mmHg

700 (66.8%)

687 (75.1%)

<0.001

SBP/DBP < 130/80 mmHg

323 (30.8%)

381 (41.6%)

<0.001

LDL-C < 2.6 mmol/L

154 (27.3%)

132 (39.4%)

<0.001

Predicted cardiovascular risk (%)

Framingham 10-year CVD riskb

35.18 ± 20.68

33.32 ± 20.16

0.0882

UKPDS 10-year CHD riskc

23.25 ± 16.29

22.00 ± 15.90

0.177

UKPDS 10-year stroke riskd

14.51 ± 15.21

15.06 ± 15.79

0.6439

  1. aIndependent t-test for continuous variables and Chi square test for dichotomous variables.
  2. bPredicted by the Framingham cardiovascular risk function.
  3. cPredicted by the UKPDS CHD risk engine.
  4. dPredicted by the UKPDS stroke risk engine.
  5. BMI, body mass index; CVD, cardiovascular disease; CHD, coronary heart disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HDL-C, high density lipid cholesterol; HKE, Hong Kong East Cluster; KCC, Kowloon Central Cluster; KWC, Kowloon West Cluster; LDL-C, low density lipid cholesterol; NTEC, New Territories East Cluster; TC, total cholesterol. T2DM, Type 2 diabetes mellitus.